PET-CT in the staging and treatment of non-small-cell lung cancer

被引：15

作者：

Ibeas, Patricia ^{[1
]}

Cantos, Blanca ^{[1
]}

Manuel Gasent, Jose ^{[1
]}

Rodriguez, Begona ^{[2
]}

Provencio, Mariano ^{[1
]}

机构：

[1] Hosp Univ Puerta Hierro Majadahonda, Med Oncol Serv, ES-28222 Madrid, Spain

[2] Hosp Univ Puerta Hierro Majadahonda, Nucl Med Serv, ES-28222 Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2011年 / 13卷 / 06期

关键词：

PET; Lung; Cancer; Diagnose; CT/PET; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; GROSS TUMOR VOLUME; FDG-PET; COMPUTED-TOMOGRAPHY; F-18; FLUORODEOXYGLUCOSE; PROGNOSTIC VALUE; HIGH-IMPACT; MEDIASTINAL METASTASES; RADICAL RADIOTHERAPY;

D O I：

10.1007/s12094-011-0670-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Positron emission tomography with 2-(F-18)-fluoro-2-deoxy-D-glucose (FDG-PET) is a metabolic imaging technique. FDG-PET is more accurate than CT for the evaluation of mediastinal involvement in patients with non-small-cell lung cancer, offering a high negative predictive value. It can detect occult metastases in 11% of patients, although the etiology of the extrathoracic isolated uptakes needs confirmation. Theoretically, FDG-PET can influence the planning volume for radiotherapy, primarily in patients with atelectasis. Quantification of metabolic activity using FDG-PET is influenced by the size of the lesion, glucose levels and the time elapsed since the isotope injection. More clinical trials are required to standardize the methods for performing PET, assess its use as a prognostic factor and for the evaluation of treatment response.

引用

页码：368 / 377

页数：10

共 129 条

[1]

Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.3.CO

[2]

2-#

[3] Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography [J].

Al-Sarraf, Nael ;

Aziz, Rashid ;

Gately, Kathy ;

Lucey, Julie ;

Wilson, Lorraine ;

McGovern, Eillish ;

Young, Vincent .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (01) :104-109

[4]

Allen MS, 2003, ANN THORAC SURG, V75, P235

[5] Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer [J].

Alongi, Filippo ;

Ragusa, Pietro ;

Montemaggi, Paolo ;

Bona, Cristina Maria .

TUMORI JOURNAL, 2006, 92 (04) :327-333

[6] Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging [J].

Antoch, G ;

Stattaus, J ;

Nemat, AT ;

Marnitz, S ;

Beyer, T ;

Kuehl, H ;

Bockisch, A ;

Debatin, JF ;

Freudenberg, LS .

RADIOLOGY, 2003, 229 (02) :526-533

[7] Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration [J].

Aquino, SL ;

Asmuth, JC ;

Alpert, NM ;

Halpern, EF ;

Fischman, AJ .

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2003, 27 (04) :479-484

[8] The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer [J].

Ashamalla, H ;

Rafla, S ;

Parikh, K ;

Mokhtar, B ;

Goswami, G ;

Kambam, S ;

Abdel-Dayem, H ;

Guirguis, A ;

Ross, P ;

Evola, A .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (04) :1016-1023

[9]

Bar-Shalom R, 2003, J NUCL MED, V44, P1200

[10]

Behzadi A, 2009, CAN J SURG, V52, P235

← 1 2 3 4 5 6 7 8 9 10 →